Description
Nutricost Maca Root Capsules provide a convenient way to add Maca Root (Lepidium meyenii) to your daily supplement routine. Each serving contains 750mg of Maca Root, and the bottle includes 180 capsules for 180 servings, making it a practical option for consistent daily use.
Maca, scientifically known as Lepidium meyenii, is a plant traditionally associated with the high-altitude regions of the Peruvian Andes. Maca root has been used as part of traditional wellness practices for generations and is now commonly available as a dietary supplement in capsule form.
Key Features
- 750mg Maca Root per serving
- Contains Lepidium meyenii
- 180 capsules
- 180 servings per bottle
- Convenient capsule format
- Easy to include in a daily supplement routine
- Manufactured by Nutricost
Convenient Maca Root Supplement
Nutricost Maca Root Capsules are designed for individuals who prefer the convenience of capsules instead of powdered maca. With 180 servings in one bottle, this supplement provides a simple option for incorporating maca root into a regular wellness routine.
What Is Maca Root?
Maca is a botanical traditionally cultivated in the Andes of Peru. The root of the maca plant is commonly used in food and dietary supplements. It is available in several varieties and is valued as a traditional plant-based ingredient.
Simple Daily Supplementation
The capsule format makes Nutricost Maca Root easy to store, carry, and use as part of your daily supplement routine. Follow the manufacturer’s label for the recommended serving size and directions for use.
If you are searching for Maca Root Capsules 750mg, Lepidium meyenii supplements, or a convenient Maca Root supplement, Nutricost Maca Root Capsules offer a straightforward capsule-based option with 180 servings per bottle.
Note: This product is a dietary supplement. Follow the manufacturer’s recommended use and consult a qualified healthcare professional if you have questions about adding a supplement to your routine.





























Reviews
There are no reviews yet.